Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 29-Sep-2022
No. of pages: 104
Inquire Before Buying

Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.

Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Recombinant Human Serum Albumin market is projected to reach US$ 113.6 million by 2028 from an estimated US$ 75 million in 2022, at a CAGR of 7.2% during 2023 and 2028.

Global recombinant human serum albumin key players include Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, etc. Global top 2 manufacturers hold a revenue sales market share over 80%. North America is the largest market, with a share about 58%, followed by Europe.In terms of product, ScrHSA is the largest segment, with a share over 90%. And in terms of application, the largest application is cell culture media, followed by medical supplements.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin.

The Recombinant Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Recombinant Human Serum Albumin market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Albumedix

- Merck

- Ventria (InVitria)

- NCPC

- Oryzogen

- HiMedia

Product Type Insights

Global markets are presented by Recombinant Human Serum Albumin type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Recombinant Human Serum Albumin are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Recombinant Human Serum Albumin Segment by Type

- OsrHSA

- ScrHSA

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Recombinant Human Serum Albumin market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Recombinant Human Serum Albumin market.

Recombinant Human Serum Albumin Segment by Application

- Cell Culture Media

- Medical Supplements

- Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Recombinant Human Serum Albumin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Serum Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Recombinant Human Serum Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Recombinant Human Serum Albumin industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Serum Albumin

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Recombinant Human Serum Albumin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Serum Albumin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Market by Application
1.3.1 Global Recombinant Human Serum Albumin Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Serum Albumin Market Size Estimates and Forecasts
2.1.1 Global Recombinant Human Serum Albumin Revenue 2017-2028
2.1.2 Global Recombinant Human Serum Albumin Sales 2017-2028
2.2 Recombinant Human Serum Albumin Market Size by Region: 2022 Versus 2028
2.3 Recombinant Human Serum Albumin Sales by Region (2017-2028)
2.3.1 Global Recombinant Human Serum Albumin Sales by Region: 2017-2022
2.3.2 Global Recombinant Human Serum Albumin Sales Forecast by Region (2023-2028)
2.3.3 Global Recombinant Human Serum Albumin Sales Market Share by Region (2017-2028)
2.4 Recombinant Human Serum Albumin Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Recombinant Human Serum Albumin Revenue by Region: 2017-2022
2.4.2 Global Recombinant Human Serum Albumin Revenue Forecast by Region (2023-2028)
2.4.3 Global Recombinant Human Serum Albumin Revenue Market Share by Region (2017-2028)
3 Global Recombinant Human Serum Albumin by Manufacturers
3.1 Global Top Recombinant Human Serum Albumin Manufacturers by Sales
3.1.1 Global Recombinant Human Serum Albumin Sales by Manufacturer (2017-2022)
3.1.2 Global Recombinant Human Serum Albumin Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Recombinant Human Serum Albumin Manufacturers by Revenue
3.2.1 Global Recombinant Human Serum Albumin Revenue by Manufacturer (2017-2022)
3.2.2 Global Recombinant Human Serum Albumin Revenue Share by Manufacturer (2017-2022)
3.3 Global Recombinant Human Serum Albumin Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Recombinant Human Serum Albumin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Recombinant Human Serum Albumin Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Recombinant Human Serum Albumin Manufacturing Base Distribution, Product Type
3.5.1 Recombinant Human Serum Albumin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Recombinant Human Serum Albumin Product Type
3.5.3 Date of International Manufacturers Enter into Recombinant Human Serum Albumin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Albumedix
4.1.1 Albumedix Corporation Information
4.1.2 Albumedix Description, Business Overview
4.1.3 Albumedix Recombinant Human Serum Albumin Products Offered
4.1.4 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Albumedix Recombinant Human Serum Albumin Sales by Product in 2021
4.1.6 Albumedix Recombinant Human Serum Albumin Sales by Application in 2021
4.1.7 Albumedix Recombinant Human Serum Albumin Sales by Geographic Area in 2021
4.1.8 Albumedix Recent Developments
4.2 Merck
4.2.1 Merck Corporation Information
4.2.2 Merck Description, Business Overview
4.2.3 Merck Recombinant Human Serum Albumin Products Offered
4.2.4 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Merck Recombinant Human Serum Albumin Sales by Product in 2021
4.2.6 Merck Recombinant Human Serum Albumin Sales by Application in 2021
4.2.7 Merck Recombinant Human Serum Albumin Sales by Geographic Area in 2021
4.2.8 Merck Recent Developments
4.3 Ventria (InVitria)
4.3.1 Ventria (InVitria) Corporation Information
4.3.2 Ventria (InVitria) Description, Business Overview
4.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered
4.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Ventria (InVitria) Recombinant Human Serum Albumin Sales by Product in 2021
4.3.6 Ventria (InVitria) Recombinant Human Serum Albumin Sales by Application in 2021
4.3.7 Ventria (InVitria) Recombinant Human Serum Albumin Sales by Geographic Area in 2021
4.3.8 Ventria (InVitria) Recent Developments
4.4 NCPC
4.4.1 NCPC Corporation Information
4.4.2 NCPC Description, Business Overview
4.4.3 NCPC Recombinant Human Serum Albumin Products Offered
4.4.4 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2017-2022)
4.4.5 NCPC Recombinant Human Serum Albumin Sales by Product in 2021
4.4.6 NCPC Recombinant Human Serum Albumin Sales by Application in 2021
4.4.7 NCPC Recombinant Human Serum Albumin Sales by Geographic Area in 2021
4.4.8 NCPC Recent Developments
4.5 Oryzogen
4.5.1 Oryzogen Corporation Information
4.5.2 Oryzogen Description, Business Overview
4.5.3 Oryzogen Recombinant Human Serum Albumin Products Offered
4.5.4 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Oryzogen Recombinant Human Serum Albumin Sales by Product in 2021
4.5.6 Oryzogen Recombinant Human Serum Albumin Sales by Application in 2021
4.5.7 Oryzogen Recombinant Human Serum Albumin Sales by Geographic Area in 2021
4.5.8 Oryzogen Recent Developments
4.6 HiMedia
4.6.1 HiMedia Corporation Information
4.6.2 HiMedia Description, Business Overview
4.6.3 HiMedia Recombinant Human Serum Albumin Products Offered
4.6.4 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2017-2022)
4.6.5 HiMedia Recombinant Human Serum Albumin Sales by Product in 2021
4.6.6 HiMedia Recombinant Human Serum Albumin Sales by Application in 2021
4.6.7 HiMedia Recombinant Human Serum Albumin Sales by Geographic Area in 2021
4.6.8 HiMedia Recent Development
5 Breakdown Data by Type
5.1 Global Recombinant Human Serum Albumin Sales by Type (2017-2028)
5.1.1 Global Recombinant Human Serum Albumin Sales by Type (2017-2022)
5.1.2 Global Recombinant Human Serum Albumin Sales Forecast by Type (2023-2028)
5.1.3 Global Recombinant Human Serum Albumin Sales Market Share by Type (2017-2028)
5.2 Global Recombinant Human Serum Albumin Revenue Forecast by Type (2017-2028)
5.2.1 Global Recombinant Human Serum Albumin Revenue by Type (2017-2022)
5.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Type (2023-2028)
5.2.3 Global Recombinant Human Serum Albumin Revenue Market Share by Type (2017-2028)
5.3 Recombinant Human Serum Albumin Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Recombinant Human Serum Albumin Sales by Application (2017-2028)
6.1.1 Global Recombinant Human Serum Albumin Sales by Application (2017-2022)
6.1.2 Global Recombinant Human Serum Albumin Sales Forecast by Application (2023-2028)
6.1.3 Global Recombinant Human Serum Albumin Sales Market Share by Application (2017-2028)
6.2 Global Recombinant Human Serum Albumin Revenue Forecast by Application (2017-2028)
6.2.1 Global Recombinant Human Serum Albumin Revenue by Application (2017-2022)
6.2.2 Global Recombinant Human Serum Albumin Revenue Forecast by Application (2023-2028)
6.2.3 Global Recombinant Human Serum Albumin Revenue Market Share by Application (2017-2028)
6.3 Recombinant Human Serum Albumin Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Recombinant Human Serum Albumin Market Size YoY Growth 2017-2028
7.2 North America Recombinant Human Serum Albumin Market Facts & Figures by Country
7.2.1 North America Recombinant Human Serum Albumin Sales by Country (2017-2028)
7.2.2 North America Recombinant Human Serum Albumin Revenue by Country (2017-2028)
7.3 North America Recombinant Human Serum Albumin Sales by Type
7.4 North America Recombinant Human Serum Albumin Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human Serum Albumin Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Recombinant Human Serum Albumin Market Facts & Figures by Region
8.2.1 Asia-Pacific Recombinant Human Serum Albumin Sales by Region (2017-2028)
8.2.2 Asia-Pacific Recombinant Human Serum Albumin Revenue by Region (2017-2028)
8.3 Asia-Pacific Recombinant Human Serum Albumin Sales by Type
8.4 Asia-Pacific Recombinant Human Serum Albumin Sales by Application
9 Europe
9.1 Europe Recombinant Human Serum Albumin Market Size YoY Growth 2017-2028
9.2 Europe Recombinant Human Serum Albumin Market Facts & Figures by Country
9.2.1 Europe Recombinant Human Serum Albumin Sales by Country (2017-2028)
9.2.2 Europe Recombinant Human Serum Albumin Revenue by Country (2017-2028)
9.3 Europe Recombinant Human Serum Albumin Sales by Type
9.4 Europe Recombinant Human Serum Albumin Sales by Application
10 Latin America
10.1 Latin America Recombinant Human Serum Albumin Market Size YoY Growth 2017-2028
10.2 Latin America Recombinant Human Serum Albumin Market Facts & Figures by Country
10.2.1 Latin America Recombinant Human Serum Albumin Sales by Country (2017-2028)
10.2.2 Latin America Recombinant Human Serum Albumin Revenue by Country (2017-2028)
10.3 Latin America Recombinant Human Serum Albumin Sales by Type
10.4 Latin America Recombinant Human Serum Albumin Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Recombinant Human Serum Albumin Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Recombinant Human Serum Albumin Market Facts & Figures by Country
11.2.1 Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2017-2028)
11.2.2 Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2017-2028)
11.3 Middle East and Africa Recombinant Human Serum Albumin Sales by Type
11.4 Middle East and Africa Recombinant Human Serum Albumin Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Recombinant Human Serum Albumin Supply Chain Analysis
12.2 Recombinant Human Serum Albumin Key Raw Materials and Upstream Suppliers
12.3 Recombinant Human Serum Albumin Clients Analysis
12.4 Recombinant Human Serum Albumin Sales Channel and Sales Model Analysis
12.4.1 Recombinant Human Serum Albumin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Recombinant Human Serum Albumin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Recombinant Human Serum Albumin Distributors
13 Market Dynamics
13.1 Recombinant Human Serum Albumin Industry Trends
13.2 Recombinant Human Serum Albumin Market Drivers
13.3 Recombinant Human Serum Albumin Market Challenges
13.4 Recombinant Human Serum Albumin Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Recombinant Human Serum Albumin Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of OsrHSA
Table 3. Major Manufacturers of ScrHSA
Table 4. Global Recombinant Human Serum Albumin Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Recombinant Human Serum Albumin Sales by Region (2017-2022) & (Kg)
Table 7. Global Recombinant Human Serum Albumin Sales Forecast by Region (2023-2028) & (Kg)
Table 8. Global Recombinant Human Serum Albumin Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Recombinant Human Serum Albumin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Recombinant Human Serum Albumin Sales by Manufacturer (2017-2022) & (Kg)
Table 11. Global Recombinant Human Serum Albumin Sales Share by Manufacturer (2017-2022)
Table 12. Recombinant Human Serum Albumin Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Recombinant Human Serum Albumin Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Recombinant Human Serum Albumin Price (2017-2022) & (US$/g)
Table 15. Ranking of Global Top Recombinant Human Serum Albumin Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Recombinant Human Serum Albumin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin as of 2021)
Table 18. Recombinant Human Serum Albumin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Recombinant Human Serum Albumin Product Type
Table 20. Date of International Manufacturers Enter into Recombinant Human Serum Albumin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Albumedix Corporation Information
Table 23. Albumedix Description and Business Overview
Table 24. Albumedix Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 25. Albumedix Recombinant Human Serum Albumin Product
Table 26. Albumedix Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Product in 2021
Table 27. Albumedix Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Application in 2021
Table 28. Albumedix Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2021
Table 29. Albumedix Recent Development
Table 30. Merck Corporation Information
Table 31. Merck Description and Business Overview
Table 32. Merck Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 33. Merck Recombinant Human Serum Albumin Product
Table 34. Merck Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Product in 2021
Table 35. Merck Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Application in 2021
Table 36. Merck Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2021
Table 37. Merck Recent Development
Table 38. Ventria (InVitria) Corporation Information
Table 39. Ventria (InVitria) Description and Business Overview
Table 40. Ventria (InVitria) Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 41. Ventria (InVitria) Recombinant Human Serum Albumin Product
Table 42. Ventria (InVitria) Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Product in 2021
Table 43. Ventria (InVitria) Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Application in 2021
Table 44. Ventria (InVitria) Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2021
Table 45. Ventria (InVitria) Recent Development
Table 46. NCPC Corporation Information
Table 47. NCPC Description and Business Overview
Table 48. NCPC Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 49. NCPC Recombinant Human Serum Albumin Product
Table 50. NCPC Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Product in 2021
Table 51. NCPC Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Application in 2021
Table 52. NCPC Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2021
Table 53. NCPC Recent Development
Table 54. Oryzogen Corporation Information
Table 55. Oryzogen Description and Business Overview
Table 56. Oryzogen Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 57. Oryzogen Recombinant Human Serum Albumin Product
Table 58. Oryzogen Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Product in 2021
Table 59. Oryzogen Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Application in 2021
Table 60. Oryzogen Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2021
Table 61. Oryzogen Recent Development
Table 62. HiMedia Corporation Information
Table 63. HiMedia Description and Business Overview
Table 64. HiMedia Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 65. HiMedia Recombinant Human Serum Albumin Product
Table 66. HiMedia Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Product in 2021
Table 67. HiMedia Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Application in 2021
Table 68. HiMedia Recombinant Human Serum Albumin Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2021
Table 69. Global Recombinant Human Serum Albumin Sales by Type (2017-2022) & (Kg)
Table 70. Global Recombinant Human Serum Albumin Sales Forecast by Type (2023-2028) & (Kg)
Table 71. Global Recombinant Human Serum Albumin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Global Recombinant Human Serum Albumin Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 73. Global Recombinant Human Serum Albumin Sales by Application (2017-2022) & (Kg)
Table 74. Global Recombinant Human Serum Albumin Sales Forecast by Application (2023-2028) & (Kg)
Table 75. Global Recombinant Human Serum Albumin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Global Recombinant Human Serum Albumin Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 77. North America Recombinant Human Serum Albumin Sales by Country (2017-2022) & (Kg)
Table 78. North America Recombinant Human Serum Albumin Sales by Country (2023-2028) & (Kg)
Table 79. North America Recombinant Human Serum Albumin Revenue by Country (2017-2022) & (US$ Million)
Table 80. North America Recombinant Human Serum Albumin Revenue by Country (2023-2028) & (US$ Million)
Table 81. North America Recombinant Human Serum Albumin Sales by Type (2017-2022) & (Kg)
Table 82. North America Recombinant Human Serum Albumin Sales by Application (2017-2022) & (Kg)
Table 83. Asia-Pacific Recombinant Human Serum Albumin Sales by Region (2017-2022) & (Kg)
Table 84. Asia-Pacific Recombinant Human Serum Albumin Sales by Region (2023-2028) & (Kg)
Table 85. Asia-Pacific Recombinant Human Serum Albumin Revenue by Region (2017-2028) & (US$ Million)
Table 86. Asia-Pacific Recombinant Human Serum Albumin Revenue by Region (2023-2028) & (US$ Million)
Table 87. Asia-Pacific Recombinant Human Serum Albumin Sales by Type (2017-2022) & (Kg)
Table 88. Asia-Pacific Recombinant Human Serum Albumin Sales by Application (2017-2022) & (Kg)
Table 89. Europe Recombinant Human Serum Albumin Sales by Country (2017-2022) & (Kg)
Table 90. Europe Recombinant Human Serum Albumin Sales by Country (2023-2028) & (Kg)
Table 91. Europe Recombinant Human Serum Albumin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Europe Recombinant Human Serum Albumin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Europe Recombinant Human Serum Albumin Sales by Type (2017-2022) & (Kg)
Table 94. Europe Recombinant Human Serum Albumin Sales by Application (2017-2022) & (Kg)
Table 95. Latin America Recombinant Human Serum Albumin Sales by Country (2017-2022) & (Kg)
Table 96. Latin America Recombinant Human Serum Albumin Sales by Country (2023-2028) & (Kg)
Table 97. Latin America Recombinant Human Serum Albumin Revenue by Country (2017-2022) & (US$ Million)
Table 98. Latin America Recombinant Human Serum Albumin Revenue by Country (2023-2028) & (US$ Million)
Table 99. Latin America Recombinant Human Serum Albumin Sales by Type (2017-2022) & (Kg)
Table 100. Latin America Recombinant Human Serum Albumin Sales by Application (2017-2022) & (Kg)
Table 101. Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2017-2022) & (Kg)
Table 102. Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2023-2028) & (Kg)
Table 103. Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Recombinant Human Serum Albumin Sales by Type (2017-2022) & (Kg)
Table 106. Middle East and Africa Recombinant Human Serum Albumin Sales by Application (2017-2022) & (Kg)
Table 107. Recombinant Human Serum Albumin Key Raw Materials, Industry Status and Trend
Table 108. Recombinant Human Serum Albumin Key Raw Materials and Upstream Suppliers
Table 109. Recombinant Human Serum Albumin Clients Status and Trend
Table 110. Recombinant Human Serum Albumin Typical Clients
Table 111. Recombinant Human Serum Albumin Distributors
Table 112. Recombinant Human Serum Albumin Market Trends
Table 113. Recombinant Human Serum Albumin Market Drivers
Table 114. Recombinant Human Serum Albumin Market Challenges
Table 115. Recombinant Human Serum Albumin Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Serum Albumin Product Picture
Figure 2. Global Recombinant Human Serum Albumin Sales Market Share by Type in 2021 & 2028
Figure 3. OsrHSA Product Picture
Figure 4. ScrHSA Product Picture
Figure 5. Global Recombinant Human Serum Albumin Sales Market Share by Application in 2021 & 2028
Figure 6. Cell Culture Media Examples
Figure 7. Medical Supplements Examples
Figure 8. Other Examples
Figure 9. Recombinant Human Serum Albumin Report Years Considered
Figure 10. Global Recombinant Human Serum Albumin Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Recombinant Human Serum Albumin Market Size 2017-2028 (US$ Million)
Figure 12. Global Recombinant Human Serum Albumin Sales 2017-2028 (Kg)
Figure 13. Global Recombinant Human Serum Albumin Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Recombinant Human Serum Albumin Revenue Market Share by Region (2017-2028)
Figure 16. Global Recombinant Human Serum Albumin Sales Share by Manufacturer in 2021
Figure 17. Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Type (2017-2028)
Figure 19. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Recombinant Human Serum Albumin Average Selling Price (ASP) by Type (2017-2022) & (US$/g)
Figure 21. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Recombinant Human Serum Albumin Average Selling Price (ASP) by Application (2017-2022) & (US$/g)
Figure 24. North America Recombinant Human Serum Albumin Revenue 2017-2028 (US$ Million)
Figure 25. North America Recombinant Human Serum Albumin Sales Market Share by Type (2017-2022)
Figure 26. North America Recombinant Human Serum Albumin Sales Market Share by Application (2017-2022)
Figure 27. Asia-Pacific Recombinant Human Serum Albumin Revenue 2017-2028 (US$ Million)
Figure 28. Asia-Pacific Recombinant Human Serum Albumin Sales Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Recombinant Human Serum Albumin Revenue Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Recombinant Human Serum Albumin Sales Market Share by Type (2017-2022)
Figure 31. Asia-Pacific Recombinant Human Serum Albumin Sales Market Share by Application (2017-2022)
Figure 32. Europe Recombinant Human Serum Albumin Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Europe Recombinant Human Serum Albumin Sales Market Share by Country (2017-2028)
Figure 34. Europe Recombinant Human Serum Albumin Revenue Market Share by Country (2017-2028)
Figure 35. Europe Recombinant Human Serum Albumin Sales Market Share by Type (2017-2022)
Figure 36. Europe Recombinant Human Serum Albumin Sales Market Share by Application (2017-2022)
Figure 37. Latin America Recombinant Human Serum Albumin Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Latin America Recombinant Human Serum Albumin Sales Market Share by Country (2017-2028)
Figure 39. Latin America Recombinant Human Serum Albumin Revenue Market Share by Country (2017-2022)
Figure 40. Latin America Recombinant Human Serum Albumin Sales Market Share by Type (2017-2022)
Figure 41. Latin America Recombinant Human Serum Albumin Sales Market Share by Application (2017-2022)
Figure 42. Middle East and Africa Recombinant Human Serum Albumin Revenue Growth Rate 2017-2028 (US$ Million)
Figure 43. Middle East and Africa Recombinant Human Serum Albumin Sales Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Recombinant Human Serum Albumin Revenue Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Recombinant Human Serum Albumin Sales Market Share by Type (2017-2022)
Figure 46. Middle East and Africa Recombinant Human Serum Albumin Sales Market Share by Application (2017-2022)
Figure 47. Recombinant Human Serum Albumin Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Recombinant Human Serum Albumin Raw Materials by Region in 2021
Figure 49. Recombinant Human Serum Albumin Distribution Channels
Figure 50. Global Recombinant Human Serum Albumin Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 51. Global Recombinant Human Serum Albumin Percentage 2017-2028: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
  • Global Antisense Oligonucleotide Drugs (ASO Drugs) Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 88
    A class of molecular drugs that inhibit gene expression and regulate at the gene level through sequence specific binding with target gene DNA or mRNA Highlights The global Antisense Oligonucleotide Drugs(ASO Drugs) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Antisense Oligonucleotide Drugs(ASO Drugs) is estimated to increase from $ million in 2022 to reach $ million by ......
  • Global RNAi Drugs Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 92
    It refers to the highly conservative, double stranded RNA induced, highly specific degradation of homologous mRNA in the evolutionary process Highlights The global RNAi Drugs market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for RNAi Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.......
  • Global Non-PVC Soft Bag Infusion Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 91
    Highlights The global Non-PVC Soft Bag Infusion market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Non-PVC Soft Bag Infusion is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Non-PVC Soft Bag Infusion is estimated to increase from $ million in 2022 to reach $ milli......
  • Global Dispense Powder Injections Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 94
    Dispensing powder injection is a powdery article formed by disinfection and drying after mixing drugs and reagents, which is convenient for transportation and preservation. When applied, it is diluted with glucose solution for injection, and the injection can be diluted according to different dosages and can be injected directly. Highlights The global Dispense Powder Injections market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % du......
  • Global Carbohydrate and Electrolyte Injection Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 94
    Carbohydrate and electrolyte injection, which can replenish energy and electrolytes for the human body, contains glucose, sodium, zinc, calcium, magnesium, potassium trace elements. For patients with a large amount of dehydration, such as severe diarrhea, vomiting, and long-term inability to eat and cannot be administered orally, mixed sugar electrolyte injections can be used to supplement the energy of the above trace elements and glucose. Highlights The global Carbohydrate and El......
  • Global Colloidal Bismuth Pectin Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 88
    Highlights The global Colloidal Bismuth Pectin market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Colloidal Bismuth Pectin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. Asia-Pacific market for Colloidal Bismuth Pectin is estimated to increase from $ million in 2022 to reach $ million ......
  • Global Dendritic Cell Therapy Vaccine Market Research Report 2022
    Published: 02-Dec-2022        Price: US 2900 Onwards        Pages: 102
    Dendritic cells are antigen-presenting cells found in lymphoid organs, their primary role is to activate T cells and display antigens. Antigen display aids in pathogen and microbe recognition by T-cells, allowing for their eradication and identification from the body. These cells aid in the capture and processing of tumor antigens, resulting in the activation of lymphocyte co-stimulatory molecules and the production of cytokines to trigger the immune response. Highlights The global......
  • Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
    Published: 02-Dec-2022        Price: US 4950 Onwards        Pages: 253
    “Increasing adoption of biopharmaceuticals and technological advancements in API manufacturing is expected to drive the overall growth of the global APIs market.” The global Active Pharmaceutical Ingredient (APIs) market is estimated to reach USD 145.9 billion by 2022 to USD 216.4 billion in 2027, at a CAGR of 8.2% during the forecast period. Factors such as the increasing uptake of biopharmaceuticals, the growing importance of generics, and the rising foc......
  • Global Human Hyperimmune Globulins Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 01-Dec-2022        Price: US 5600 Onwards        Pages: 112
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Human Hyperimmune Globulins is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China mar......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs